Efforts to Personalize Radiation Therapies with Predictive Biomarkers Described at AACR Annual Meeting

As more and more cancer therapies are tailored to individual tumors, the search for predictive biomarkers in radiation oncology remains ongoing. A comprehensive approach is needed to look at multiple components that can influence response to radiotherapy, said Silvia C. Formenti, MD, Weill Cornell Medicine. Targeted approaches could include looking at the tumor microenvironment, the host microbiome, the tumor stage, the time of radiation, and the genetic characteristics of the host. Dr. Formenti chaired an AACR Annual Meeting symposium on Monday, April 11, that included three presentations exploring current research in some of these areas. This session, Predictive Biomarkers for Precision Radiation Oncology, and others, can be viewed on the virtual platform by registered meeting participants through July 13, 2022. Registration can be done here. Over 19,000 scientists and physicians registered for this premier cancer conference, with ~80% (~15,200) attending in person and ~20% (~3,800) attending virtually. The AACR has over 50,000 members worldwide. The live American Association for Cancer Research (AACR) Annual Meeting, ran April 8-13 in New Orleans.